These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37142131)

  • 1. Putting square pegs in round holes: Why traditional pharmacokinetic principles cannot universally be applied to iron-carbohydrate complexes.
    Alston AB; Digigow R; Flühmann B; Wacker MG
    Eur J Pharm Biopharm; 2023 Jul; 188():6-14. PubMed ID: 37142131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing safety and efficacy of intravenous iron-carbohydrate nanomedicines: From production to clinical practice.
    Nikravesh N; Borchard G; Hofmann H; Philipp E; Flühmann B; Wick P
    Nanomedicine; 2020 Jun; 26():102178. PubMed ID: 32145382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criticality of Surface Characteristics of Intravenous Iron-Carbohydrate Nanoparticle Complexes: Implications for Pharmacokinetics and Pharmacodynamics.
    Funk F; Flühmann B; Barton AE
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snapshots of Iron Speciation: Tracking the Fate of Iron Nanoparticle Drugs via a Liquid Chromatography-Inductively Coupled Plasma-Mass Spectrometric Approach.
    Neu HM; Alexishin SA; Brandis JEP; Williams AMC; Li W; Sun D; Zheng N; Jiang W; Zimrin A; Fink JC; Polli JE; Kane MA; Michel SLJ
    Mol Pharm; 2019 Mar; 16(3):1272-1281. PubMed ID: 30676753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical nanomaterial attributes of iron-carbohydrate nanoparticles: Leveraging orthogonal methods to resolve the 3-dimensional structure.
    Krupnik L; Joshi P; Kappler A; Flühmann B; Alston AB; Digigow R; Wick P; Neels A
    Eur J Pharm Sci; 2023 Sep; 188():106521. PubMed ID: 37423578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate.
    Brandis JEP; Kihn KC; Taraban MB; Schnorr J; Confer AM; Batelu S; Sun D; Rodriguez JD; Jiang W; Goldberg DP; Langguth P; Stemmler TL; Yu YB; Kane MA; Polli JE; Michel SLJ
    Mol Pharm; 2021 Apr; 18(4):1544-1557. PubMed ID: 33621099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients.
    Martin-Malo A; Borchard G; Flühmann B; Mori C; Silverberg D; Jankowska EA
    ESC Heart Fail; 2019 Apr; 6(2):241-253. PubMed ID: 30694615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexity of intravenous iron nanoparticle formulations: implications for bioequivalence evaluation.
    Pai AB
    Ann N Y Acad Sci; 2017 Nov; 1407(1):17-25. PubMed ID: 29027212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into iron deficiency and iron deficiency anemia.
    Camaschella C
    Blood Rev; 2017 Jul; 31(4):225-233. PubMed ID: 28216263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
    Lyseng-Williamson KA; Keating GM
    Drugs; 2009; 69(6):739-56. PubMed ID: 19405553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano-scale characterization of iron-carbohydrate complexes by cryogenic scanning transmission electron microscopy: Building the bridge to biorelevant characterization.
    Digigow R; Burgert M; Luechinger M; Sologubenko A; Rzepiela AJ; Handschin S; Alston AEB; Flühmann B; Philipp E
    Heliyon; 2024 Sep; 10(17):e36749. PubMed ID: 39281449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution and targeting properties of iron oxide nanoparticles for treatments of cancer and iron anemia disease.
    Alphandéry E
    Nanotoxicology; 2019 Jun; 13(5):573-596. PubMed ID: 30938215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Ferric Carboxymaltose in Chinese Patients with Iron-deficiency Anemia.
    Ding Y; Zhu X; Li X; Zhang H; Wu M; Liu J; Palmen M; Roubert B; Li C
    Clin Ther; 2020 Feb; 42(2):276-285. PubMed ID: 31937462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of iron-deficiency anaemia in pregnancy and postpartum.
    Breymann C; Honegger C; Hösli I; Surbek D
    Arch Gynecol Obstet; 2017 Dec; 296(6):1229-1234. PubMed ID: 28940095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
    Geisser P; Banké-Bochita J
    Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue biodistribution of intravenous iron-carbohydrate nanomedicines differs between preparations with varying physicochemical characteristics in an anemic rat model.
    Funk F; Weber K; Nyffenegger N; Fuchs JA; Barton A
    Eur J Pharm Biopharm; 2022 May; 174():56-76. PubMed ID: 35337966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid lipid nanoparticles loaded with iron to overcome barriers for treatment of iron deficiency anemia.
    Hosny KM; Banjar ZM; Hariri AH; Hassan AH
    Drug Des Devel Ther; 2015; 9():313-20. PubMed ID: 25609917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial.
    Macdougall IC; Bock AH; Carrera F; Eckardt KU; Gaillard C; Van Wyck D; Meier Y; Larroque S; Roger SD;
    BMC Nephrol; 2017 Jan; 18(1):24. PubMed ID: 28095881
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.